ENDOLOGIX INC - NOTE 3.250%11/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2020

Type / Class
Debt / NOTE 3.250%11/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ENDOLOGIX INC - NOTE 3.250%11/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$3,760,000 0
2019 Q4 $4,000,000 $3,760,000 94.0% 1
2019 Q3 $4,000,000 $3,835,000 -$1,305,000 95.88% 1
2019 Q2 $10,995,000 $5,140,000 -$55,068,000 61.4% 2
2019 Q1 $84,350,000 $58,611,000 68.46% 5
2018 Q4 $84,350,000 $59,258,000 +$4,146 71.43% 5
2018 Q3 $88,405,000 $61,302,000 -$39,400,489 69.09% 7
2018 Q2 $124,755,000 $115,608,000 +$141,885 91.9% 9
2018 Q1 $124,605,000 $107,446,000 -$169,745 86.0% 9
2017 Q4 $124,775,000 $112,802,000 +$39,246 90.78% 10
2017 Q3 $124,775,000 $107,870,000 -$771,842 86.47% 10
2017 Q2 $126,300,000 $107,237,000 -$35,229 85.57% 13
2017 Q1 $126,400,000 $124,886,000 -$6,860,374 98.82% 12
2016 Q4 $134,275,000 $117,403,000 -$14,695,983 87.38% 13
2016 Q3 $125,392,000 $166,421,000 -$1,057,429 132.45% 16
2016 Q2 $126,192,000 $164,640,000 +$21,095,098 130.45% 14
2016 Q1 $124,250,000 $119,870,000 +$20,749,527 96.06% 14
2015 Q4 $101,105,000 $109,779,190 +$97,288,000 108.56% 14